Equity Investing
What’s the reason behind the decline of Medicenna Therapeutics Corp. (MDNA) stock?
Medicenna Therapeutics Corp. (MDNA) experienced a decrease of 10.67% in the aftermarket. However, the last trading session closed at $2.25. FDA Clearance of IND to